Donor derived cell free Deoxyribonucleic acid (DNA) testing

The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 7 (Ralph H. Johnson VA Healthcare System), seeks donor-derived cell-free DNA testing services via an unrestricted IDIQ contract with proposals due August 31, 2026.

The contract ceiling is $41.5 million over a five-year period of performance spanning October 15, 2026 through October 14, 2031 (base year plus four option years). Place of performance is Charleston, South Carolina. The procurement requires FDA-approved, clinically validated donor-derived cell-free DNA testing to support kidney transplant patients for potential rejection monitoring. The contractor must deliver test results within three business days of specimen receipt via electronic means, supply complete test kits with all necessary materials and return postage, and provide mobile phlebotomy services for geographically remote patients. All contractor work is performed at the contractor's laboratory with results reported securely to the kidney transplant team.

Estimated quantities are 92 tests in the base year, with anticipated increases to 193, 258, 281, and 304 tests in option years one through four, respectively. The contractor must maintain all required licenses, certifications, and accreditations. The Services Contract Act applies with wage determination requirements for each option year. Comprehensive IT security and privacy requirements apply, including Business Associate Agreement compliance for protected health information handling. Liquidated damages of $37.50 per affected individual are imposed for data breaches. Invoices are submitted monthly with payment by electronic funds transfer. NAICS code 621511 (Medical Laboratories) applies. This procurement was previously solicited as a Small Business set-aside but received no SB quotes; it is now unrestricted.